TREATMENT OF DISSEMINATED BREAST CANCER WITH TAMOXIFEN, AMINOGLUTETHIMIDE, HYDROCORTISONE, AND DANAZOL, USED IN COMBINATION OR SEQUENTIALLY
- 1 June 1984
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 323 (8391) , 1369-1373
- https://doi.org/10.1016/s0140-6736(84)91872-5
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Tamoxifen, aminoglutethimide and danazol: effect of therapy on hormones in post-menopausal patients with breast cancerBritish Journal of Cancer, 1982
- Effects of endocrine therapy on steroid-receptor content of breast cancerBritish Journal of Cancer, 1982
- Assessment of response to therapy in advanced breast cancer.A project of the programme on clinical oncology of the International Union against Cancer, Geneva, SwitzerlandCancer, 1977
- Randomized sequential hormonal therapy vs adrenalectomy for metastatic breast carcinomaCancer, 1977
- Disseminated breast cancer: Evaluation of hormonal therapy utilizing stilbestrol and medrogestone (AY-62022) singly and in combinationCancer, 1972
- Treatment of Breast Cancer with Medroxyprogesterone AcetateAnnals of Internal Medicine, 1968
- Delalutin and estrogens for the treatment of advanced mammary carcinoma in the postmenopausal womanCancer, 1965
- Combined estrogenic and androgenic hormone therapy in advanced breast cancerCancer, 1965
- TREATMENT OF ADVANCED CARCINOMA OF THE BREAST BY BILATERAL OOPHORECTOMY AND PREDNISONEThe Lancet, 1960